MRE as a Screening Tool for axSpA in IBD (ProSpA-CD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03817983 |
|
Recruitment Status :
Completed
First Posted : January 28, 2019
Last Update Posted : March 15, 2022
|
Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Jobie Evans, Cambridge University Hospitals NHS Foundation Trust
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 8, 2020 |
| Actual Study Completion Date : | August 8, 2020 |
| Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
|---|---|---|
| 1 |
July 23, 2022 |